We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
GlaxoSmithKline has been remaking its emerging markets operations to be more efficient and cost effective and a manufacturing plant and 1,000 employees in Bangladesh are the next to be streamlined into extinction.